ORTHOSORB ABSORBABLE PIN 84-1052

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 1998-01-16 for ORTHOSORB ABSORBABLE PIN 84-1052 manufactured by Johnson & Johnson Professionals, Inc..

Event Text Entries

[86645] The pt had a hammertoe plasty of the second toe. The toe became markedly inflamed and irritated. Pt was admitted to the hosp for antibiotic therapy, debridement of the second toe, and removal of implant due to probable allergic reaction to the synthetic implant. A stainless steel pin was used to transfix the arthroplasty sites.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219655-1998-00007
MDR Report Key144275
Report Source06
Date Received1998-01-16
Date of Report1998-01-16
Date of Event1997-10-24
Date Mfgr Received1997-12-17
Date Added to Maude1998-01-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameORTHOSORB ABSORBABLE PIN
Generic NameABSORBABLE PIN
Product CodeMBJ
Date Received1998-01-16
Model NumberNA
Catalog Number84-1052
Lot Number138BE
ID NumberNI
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Implant FlagY
Date RemovedV
Device Sequence No1
Device Event Key140696
ManufacturerJOHNSON & JOHNSON PROFESSIONALS, INC.
Manufacturer Address325 PARAMOUNT DRIVE RAYNHAM MA 02767 US
Baseline Brand NameORTHOSORB ABSORBABLE PIN
Baseline Generic NameABSORBABLE PIN
Baseline Model NoNA
Baseline Catalog No84-1052
Baseline ID*
Baseline Device FamilyORTHOSORB ABSORBABLE PIN
Baseline Shelf Life Contained*
Baseline Shelf Life [Months]60
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK864912
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 1998-01-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.